Anders Sundström

5.6k total citations · 2 hit papers
70 papers, 3.7k citations indexed

About

Anders Sundström is a scholar working on Surgery, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anders Sundström has authored 70 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Dermatology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anders Sundström's work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Pharmaceutical studies and practices (6 papers). Anders Sundström is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (8 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Pharmaceutical studies and practices (6 papers). Anders Sundström collaborates with scholars based in Sweden, United States and Denmark. Anders Sundström's co-authors include Ulf Bergman, Björn Wettermark, Ingemar Persson, Måns Rosén, Petra Otterblad Olausson, B Westerholm, Niklas Hammar, Helle Kieler, David Hägg and Marcus Schmitt‐Egenolf and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anders Sundström

65 papers receiving 3.6k citations

Hit Papers

The new Swedish Prescribed Drug Register—Opportunities fo... 2006 2026 2012 2019 2006 2022 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
    2006 1.5k citations Björn Wettermark, Ingemar Persson et al. Pharmacoepidemiology and Drug Safety profile →
  2. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
    2022 127 citations Øystein Karlstad, Nicklas Pihlström et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Sundström Sweden 29 597 548 507 421 416 70 3.7k
Raymond G. Schlienger Switzerland 34 565 0.9× 759 1.4× 286 0.6× 203 0.5× 507 1.2× 81 4.0k
Edward Chia‐Cheng Lai Taiwan 28 408 0.7× 411 0.8× 308 0.6× 257 0.6× 573 1.4× 162 3.1k
Rhonda L. Bohn United States 28 695 1.2× 729 1.3× 269 0.5× 209 0.5× 225 0.5× 83 3.5k
Colin R. Dormuth Canada 35 763 1.3× 547 1.0× 461 0.9× 496 1.2× 368 0.9× 115 4.3k
Xavier Kurz Netherlands 31 981 1.6× 509 0.9× 224 0.4× 279 0.7× 281 0.7× 92 3.5k
Bruce Carleton Canada 43 451 0.8× 815 1.5× 290 0.6× 740 1.8× 416 1.0× 236 6.4k
David Wonderling United Kingdom 25 753 1.3× 464 0.8× 217 0.4× 270 0.6× 288 0.7× 47 3.1k
Patrick C. Souverein Netherlands 35 717 1.2× 822 1.5× 887 1.7× 200 0.5× 501 1.2× 201 4.4k
Eswar Krishnan United States 50 1.7k 2.9× 449 0.8× 321 0.6× 438 1.0× 1.0k 2.5× 113 7.5k
Antonio Addis Italy 25 344 0.6× 226 0.4× 167 0.3× 945 2.2× 308 0.7× 121 2.7k

Countries citing papers authored by Anders Sundström

Since Specialization
Citations

This map shows the geographic impact of Anders Sundström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Sundström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Sundström more than expected).

Fields of papers citing papers by Anders Sundström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Sundström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Sundström. The network helps show where Anders Sundström may publish in the future.

Co-authorship network of co-authors of Anders Sundström

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Sundström. A scholar is included among the top collaborators of Anders Sundström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Sundström. Anders Sundström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ljung, Rickard, Nicklas Pihlström, Jesper Dahl, et al.. (2025). SARS-CoV-2 vaccination and myositis in Norway and Sweden. Lara D. Veeken. 65(2).
2.
Zethelius, Björn, et al.. (2024). Pulmonary embolism after SARS-CoV-2 vaccination. Vaccine X. 21. 100571–100571.
3.
Arthurson, Veronica, et al.. (2023). BERT based natural language processing for triage of adverse drug reaction reports shows close to human-level performance. SHILAP Revista de lepidopterología. 2(12). e0000409–e0000409. 7 indexed citations
4.
Eriksson, Niclas, et al.. (2023). Identification of risk factors for adverse drug reactions in a pharmacovigilance database. Pharmacoepidemiology and Drug Safety. 32(12). 1431–1438.
5.
Gedeborg, Rolf, Lennart Holm, Nils Feltelius, et al.. (2023). Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines. Upsala Journal of Medical Sciences. 128. 6 indexed citations
6.
Sundström, Anders, et al.. (2023). Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes. European Journal of Clinical Pharmacology. 80(1). 53–63. 7 indexed citations
7.
8.
Ljung, Rickard, Anders Sundström, Maria Grünewald, et al.. (2021). The profile of the COvid-19 VACcination register SAFEty study in Sweden (CoVacSafe-SE). Upsala Journal of Medical Sciences. 126. 11 indexed citations
9.
10.
Kuiper, Josephina G., Myrthe P. P. van Herk‐Sukel, Jordi Castellsagué, et al.. (2018). Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs - Real World Outcomes. 5(2). 109–116. 1 indexed citations
11.
Bruzelius, Maria, Rona J. Strawbridge, David‐Alexandre Trégouët, et al.. (2014). Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism. Thrombosis Research. 134(2). 426–432. 15 indexed citations
12.
Sörman, Daniel Eriksson, Anders Sundström, Michael Rönnlund, Rolf Adolfsson, & L.-G. Nilsson. (2013). Leisure Activity in Old Age and Risk of Dementia: A 15-Year Prospective Study. The Journals of Gerontology Series B. 69(4). 493–501. 74 indexed citations
13.
Neovius, Martin, Anders Sundström, L. Jacobsson, et al.. (2010). Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register. Annals of the Rheumatic Diseases. 70(3). 516–519. 52 indexed citations
14.
Sundström, Anders, et al.. (2010). A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting system. European Journal of Clinical Pharmacology. 66(9). 947–953. 129 indexed citations
15.
Neovius, Martin, Anders Sundström, Björn Wettermark, et al.. (2010). Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009. Scandinavian Journal of Rheumatology. 40(1). 8–15. 49 indexed citations
16.
Sundström, Anders, Börje Åkerlund, Anders Karlsson, et al.. (2010). Increased risk of abdominal wall hernia associated with combination anti‐retroviral therapy in HIV‐infected patients—results from a Swedish cohort‐study. Pharmacoepidemiology and Drug Safety. 19(5). 465–473. 3 indexed citations
17.
Wallerstedt, Susanna M., et al.. (2009). Risk of clinically relevant bleeding in warfarin‐treated patients—influence of SSRI treatment. Pharmacoepidemiology and Drug Safety. 18(5). 412–416. 49 indexed citations
18.
Eland, Ingo A., Anders Sundström, Morten Andersen, et al.. (2006). Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP). Scandinavian Journal of Gastroenterology. 41(12). 1484–1490. 49 indexed citations
19.
Hedenmalm, Karin, Anders Sundström, & Olav Spigset. (2006). Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Pharmacoepidemiology and Drug Safety. 15(10). 719–725. 19 indexed citations
20.
Sundström, Anders, et al.. (2005). Acid‐suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis—results from a Swedish Case‐Control Study. Pharmacoepidemiology and Drug Safety. 15(3). 141–149. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond G. Schlienger Breakdown of academic impact, for papers by Edward Chia‐Cheng Lai Breakdown of academic impact, for papers by Rhonda L. Bohn Breakdown of academic impact, for papers by Colin R. Dormuth Breakdown of academic impact, for papers by Xavier Kurz Breakdown of academic impact, for papers by Bruce Carleton Breakdown of academic impact, for papers by David Wonderling Breakdown of academic impact, for papers by Patrick C. Souverein Breakdown of academic impact, for papers by Eswar Krishnan Breakdown of academic impact, for papers by Antonio Addis
Rankless by CCL
2026